Cutler Group’s Tandem Diabetes Care TNDM Stock Holding History

Cutler Group’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,500	Closed	-$3K	–	5224
2022 Q3	$3K	Buy	+1,500	New	+$82.2K	﹤0.01%	4045
2022 Q1	–	Sell	-200	Closed	-$16K	–	6046
2021 Q4	$16K	Hold	200	–	–	﹤0.01%	3318
2021 Q3	$10K	Sell	200 -2,300	-92%	-$253K	﹤0.01%	3955
2021 Q2	$17K	Buy	2,500 +800	+47%	+$71.3K	﹤0.01%	3455
2021 Q1	$11K	Buy	+1,700	New	+$158K	﹤0.01%	3747
2019 Q4	–	Sell	-1,800	Closed	-$1K	–	4605
2019 Q3	$1K	Buy	1,800 +1,500	+500%	+$95.7K	﹤0.01%	3835
2019 Q2	$1K	Sell	300 -14,900	-98%	-$962K	﹤0.01%	4003
2019 Q1	$164K	Sell	15,200 -19,100	-56%	-$1M	0.02%	747
2018 Q4	$38K	Sell	34,300 -19,800	-37%	-$699K	﹤0.01%	1660
2018 Q3	$272K	Buy	54,100 +41,700	+336%	+$1.46M	0.02%	703
2018 Q2	$150K	Buy	+12,400	New	+$152K	0.01%	913

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Cutler Group's TNDM Position: Q1 2023 in Review

Cutler Group sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 171 shares — an estimated $7K sold.

Cutler Group first reported a position in TNDM in Q4 2015 and held it in 17 quarters. The position peaked at $168K in Q1 2022. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

Cutler Group reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
Cutler Group sold 171 Tandem Diabetes Care shares in Q1 2023, an estimated $7K.
Cutler Group first reported a position in Tandem Diabetes Care in Q4 2015 and held it in 17 quarters.
Cutler Group's Tandem Diabetes Care position peaked at $168K in Q1 2022.
273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.